Abstract
Most patients with dementia are not diagnosed in time and many are not detected at all. The development of dementia is preceded by mild cognitive impairment.
In the early stages of the disease, specialized examinations of biomarkers of Alzheimer's disease and other dementias and detailed neuropsychological examinations may be very useful. Evidence-based treatment for early stages of dementia is acetylcholinesterase inhibitors, which have also been tested in MCI.
The sooner we start treatment, the better we are able to delay the most serious stages of the disease. The efficacy of traditionally used nootropics and vasoactive substances has not been demonstrated in Alzheimer's disease.
An essential part of care is the support of mental activity and social ties of patients.